# US 2012/0083599 A1 · Biomolecular Labelling Using Multifunctional Biotin Analogues

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0083599 A1
- Document ID: US20120083599A1
- Status: Published application
- Kind: A1
- Application number: 13/257,562
- Filed: 2010-03-22
- Published: 2012-04-05
- Earliest claimed: 2009-03-20
- Assignees: The University of Nottingham
- Inventors: Neil R. Thomas; Yang Yong-Qing; William C. Drewe
- Web page: https://patentgrep.com/patent/US20120083599A1

## CPC

- C07D 495/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Novel biotin analogues, such as 2-Azidobiotin, comprising the ureido ring of natural biotin with the thiophene ring, optionally modified, and a modified sidechain having a functional end group, preferably selected from the group consisting of a carboxylic acid, amine, alcohol, thiol, aldehyde and a halide, and at least one bio-orthogonally reactive chemical group located elsewhere in the sidechain. The analogues are used for labelling target structures and biomolecules, such as peptides and proteins in vitro or in vivo.

## Claims

### Claim 1

A biotin analogue comprising the ureido ring of natural biotin, optionally a modified thiophene ring and a modified sidechain having a functional end group selected from the group consisting of a carboxylic acid, aldehyde, alcohol, amine, thiol and halide, and at least one bio-orthogonally reactive chemical group located elsewhere in the sidechain, wherein the bio-orthogonally reactive chemical group is selected from the group consisting of an azide, an alkyne, an alkene, a heterocyclic group, a diene group and/or one or more heteroatoms selected from S, N, Se, P and

### Claim at position 2

2-3. (canceled)

### Claim 4 (depends on 1)

A biotin analogue as claimed in claim 1, wherein the reactive group is located on, or as part of, or in place of, a valeryl side chain of the biotin analogue.

### Claim 5 (depends on 1)

A biotin analogue as claimed in claim 1, wherein the biotin analogue has the sulfur ring of the thiophene ring replaced with another group selected from the group consisting of CH2, O, NH, and C═O.

### Claim 6

(canceled)

### Claim 7

A biotin analogue as claimed in 3 having the following general formula:
wherein R has a functional end group selected from the group consisting of a carboxylic acid, aldehyde, alcohol, amine, thiol and halide and includes at least one second functional group selected from the group consisting of an azide, an alkyne, an alkene, a diene, a heterocyclic ring and/or one or more heteroatoms selected from S, N, Se, P and O located elsewhere on the sidechain.

### Claim 8

(canceled)

### Claim 9 (depends on 7)

A biotin analogue as claimed in claim 7, wherein the bio-orthogonally reactive group is positioned at any one of positions 1 to 5 of the valeryl sidechain.

### Claim 10

(canceled)

### Claim 11 (depends on 7)

A biotin analogue as claimed in claim 7, wherein R is selected from the following side chains:

### Claim 12 (depends on 7)

A biotin analogue as claimed in any one of claims 7, wherein the 5-carbon backbone of the valeryl sidechain of the analogue is maintained.

### Claim 13

(canceled)

### Claim 14 (depends on 7)

A biotin analogue as claimed in claim 7, wherein the backbone of the valeryl side chain includes one or more heteroatoms selected from the group consisting of sulphur, nitrogen, selenium, phosphorus or oxygen.

### Claim 15

A biotin analogue having a structure selected from the group consisting of:

### Claim at position 15

16-17. (canceled)

### Claim 18

A biotin analogue having the structure:
wherein X is CH2, O, NH or C═O and R has a functional end group and includes at least one second functional group selected from the group consisting of an azide, an alkyne, an alkene, a diene, a heterocyclic ring and/or one or more heteroatoms selected from S, N, Se, P and O located elsewhere on the sidechain.

### Claim 19

A biotin analogue having the structure:
wherein X is CH2, O, NH or C═O and Y is N, CH or S.

### Claim 20

A biotin analogue having the structure:
wherein X is CH2, O, NH or C═O and Y is N, CH or S.

### Claim 21

(canceled)

### Claim 22 (depends on 7)

A biotin analogue as claimed in claim 7 having the following general formula:

### Claim at position 21

23-25. (canceled)

### Claim 26 (depends on 1)

A specific target structure labelled with a biotin analogue as claimed in claim 1.

### Claim at position 23

27-33. (canceled)

### Claim 34 (depends on 1)

A method of labelling a target structure comprising a biotin analogue according to claim 1.

### Claim at position 25

35-39. (canceled)
